Myo-inositol supplementation improves cardiometabolic factors, anthropometric measures, and liver function in obese patients with non-alcoholic fatty liver disease

Myo-inositol supplementation improves cardiometabolic factors, anthropometric measures, and liver function in obese patients with non-alcoholic fatty liver disease

BackgroundNon-alcoholic fatty liver disease (NAFLD) as the hepatic manifestation of metabolic syndrome is closely associated with type 2 diabetes mellitus. Myo-inositol (MI)—a 6-C sugar alcohol—with insulin-mimetic, anti-diabetic, lipid-lowering, and anti-inflammatory properties has exerted favorabl...

Full description

Bibliographic Details
Main Authors: Sara Arefhosseini, Neda Roshanravan, Helda Tutunchi, Somayyeh Rostami, Manuchehr Khoshbaten, Mehrangiz Ebrahimi-Mameghani
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Nutrition
Subjects:
anthropometric measures
glycemic indices
lipid profile
myo-inositol
non-alcoholic fatty liver disease
NAFLD
Online Access:https://www.frontiersin.org/articles/10.3389/fnut.2023.1092544/full

Internet

https://www.frontiersin.org/articles/10.3389/fnut.2023.1092544/full

Similar Items